Published in Vaccine Weekly, January 24th, 2001
Philippe De Wals, PhD, of Sherbrooke University Hospital Center, Sherbrooke, Quebec, and colleagues studied the impact of a mass immunization campaign and assessed the vaccine effectiveness (VE) of serogroup C polysaccharide vaccine in controlling outbreaks of meningococcal disease (MCD). The authors analyzed MCD cases reported in Quebec from 1990 to 1998,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly